[Induction of dendritic cells with multidrug resistance from K562/MDR1 cells]

Zhejiang Da Xue Xue Bao Yi Xue Ban. 2011 Sep;40(5):489-94. doi: 10.3785/j.issn.1008-9292.2011.05.005.
[Article in Chinese]

Abstract

Objective: To induce the differentiation of K562/MDR1 cells into dendritic cells (DC) with multidrug resistance property.

Methods: K562/MDR1 cells and K562 cells were cultured in the presence of GM-CSF and IL-4 to generate DC and matured by TNF-α. On d14 K562/MDR1-DC and K562-DC cells were harvested and the expressions of CD1a, CD83, CD80, CD86, HLA-ABC and HLA-DR were assessed by flow cytometry (FCM). The antigen presentation function of K562/MDR1-DC and K562-DC was determined by allogenic mixed lymphocyte reaction (Allo-MLR). The expression of P-glycoprotein and the intracellular accumulation of daunorubicin (DNR) were detected by FCM. The sensitivity of K562/MDR1-DC and K562-DC cell to vincristine, adriamycin was measured using MTT assay.

Results: Both K562/MDR1 and K562 cells were differentiated into dendritic cells in the presence of cytokine cocktails, showing the morphologic and immunophenotypic characteristics of DC. K562/MDR1-DC more markedly enhanced proliferation of allogeneic lymphocytes in MLR than K562-DC. High level expression of P-glycoprotein and efflux of DNR were demonstrated in K562/MDR1-DC. K562/MDR1-DC showed multidrug resistance property, with higher IC(50) to VCR and ADM than that of K562-DCs.

Conclusion: K562/MDR1 cells can be differentiated into DC with the presence of cytokines, the induced K562/MDR1-DC cells express high level of P-glycoprotein and acquire the multidrug resistance property.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP Binding Cassette Transporter, Subfamily B, Member 1 / genetics*
  • Cell Differentiation / drug effects*
  • Dendritic Cells / cytology*
  • Drug Resistance, Multiple*
  • Granulocyte-Macrophage Colony-Stimulating Factor / pharmacology
  • Humans
  • Interleukin-4 / pharmacology
  • K562 Cells / cytology
  • Transfection
  • Tumor Necrosis Factor-alpha / pharmacology

Substances

  • ATP Binding Cassette Transporter, Subfamily B, Member 1
  • Tumor Necrosis Factor-alpha
  • Interleukin-4
  • Granulocyte-Macrophage Colony-Stimulating Factor